These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 20523342

  • 1. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
    Huang Q, Yin JY, Dai XP, Pei Q, Dong M, Zhou ZG, Huang X, Yu M, Zhou HH, Liu ZQ.
    Acta Pharmacol Sin; 2010 Jun; 31(6):709-17. PubMed ID: 20523342
    [Abstract] [Full Text] [Related]

  • 2. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
    Huang Q, Yin JY, Dai XP, Wu J, Chen X, Deng CS, Yu M, Gong ZC, Zhou HH, Liu ZQ.
    Eur J Clin Pharmacol; 2010 Dec; 66(12):1207-15. PubMed ID: 20809084
    [Abstract] [Full Text] [Related]

  • 3. The effect of IGF2BP2 gene polymorphisms on pioglitazone response in Chinese type 2 diabetes patients.
    Zhang LF, Pei Q, Yang GP, Zhao YC, Mu YF, Huang Q, Zhu YL.
    Pharmacology; 2014 Dec; 94(3-4):115-22. PubMed ID: 25247335
    [Abstract] [Full Text] [Related]

  • 4. Effects of NOS1AP rs12742393 polymorphism on repaglinide response in Chinese patients with type 2 diabetes mellitus.
    Wang T, Wang Y, Lv DM, Song JF, Lu Q, Gao X, Zhang F, Guo H, Li W, Yin XX.
    Pharmacotherapy; 2014 Feb; 34(2):131-9. PubMed ID: 24338736
    [Abstract] [Full Text] [Related]

  • 5. NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus.
    Sheng FF, Dai XP, Qu J, Lei GH, Lu HB, Wu J, Xu XJ, Pei Q, Dong M, Liu YZ, Zhou HH, Liu ZQ.
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):550-4. PubMed ID: 21631570
    [Abstract] [Full Text] [Related]

  • 6. NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.
    Gong ZC, Huang Q, Dai XP, Lei GH, Lu HB, Yin JY, Xu XJ, Qu J, Pei Q, Dong M, Zhou BT, Shen J, Zhou G, Zhou HH, Liu ZQ.
    Br J Clin Pharmacol; 2012 Sep; 74(3):501-9. PubMed ID: 22296034
    [Abstract] [Full Text] [Related]

  • 7. KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetic patients.
    Dai XP, Huang Q, Yin JY, Guo Y, Gong ZC, Lei MX, Jiang TJ, Zhou HH, Liu ZQ.
    Clin Exp Pharmacol Physiol; 2012 May; 39(5):462-8. PubMed ID: 22414228
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitus.
    Shang Z, Han F, Zhou X, Bao Z, Zhu J, Wang T, Lu Q, Du L, Li W, Lv D, Yin X.
    Drug Dev Res; 2018 May; 79(3):129-135. PubMed ID: 29663513
    [Abstract] [Full Text] [Related]

  • 12. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
    Song JF, Wang T, Zhu J, Zhou XY, Lu Q, Guo H, Zhang F, Wang Y, Li W, Wang DD, Cui YW, Lv DM, Yin XX.
    Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):27-32. PubMed ID: 25311380
    [Abstract] [Full Text] [Related]

  • 13. Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.
    Liu HL, Lin YG, Wu J, Sun H, Gong ZC, Hu PC, Yin JY, Zhang W, Wang D, Zhou HH, Liu ZQ.
    Eur J Clin Pharmacol; 2008 Jul; 64(7):663-71. PubMed ID: 18438653
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between IGF2BP2 Polymorphisms and Type 2 Diabetes Mellitus: A Case-Control Study and Meta-Analysis.
    Rao P, Wang H, Fang H, Gao Q, Zhang J, Song M, Zhou Y, Wang Y, Wang W.
    Int J Environ Res Public Health; 2016 Jun 09; 13(6):. PubMed ID: 27294943
    [Abstract] [Full Text] [Related]

  • 16. Serine racemase rs391300 G/A polymorphism influences the therapeutic efficacy of metformin in Chinese patients with diabetes mellitus type 2.
    Dong M, Gong ZC, Dai XP, Lei GH, Lu HB, Fan L, Qu J, Zhou HH, Liu ZQ.
    Clin Exp Pharmacol Physiol; 2011 Dec 09; 38(12):824-9. PubMed ID: 21933224
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients.
    Sun H, Gong ZC, Yin JY, Liu HL, Liu YZ, Guo ZW, Zhou HH, Wu J, Liu ZQ.
    Br J Clin Pharmacol; 2008 Jun 09; 65(6):917-26. PubMed ID: 18429970
    [Abstract] [Full Text] [Related]

  • 19. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.
    Eur J Endocrinol; 2008 Jan 09; 158(1):35-46. PubMed ID: 18166815
    [Abstract] [Full Text] [Related]

  • 20. Replication of association study between type 2 diabetes mellitus and IGF2BP2 in Han Chinese population.
    Zhang SM, Xiao JZ, Ren Q, Han XY, Tang Y, Yang WY, Ji LN.
    Chin Med J (Engl); 2013 Nov 09; 126(21):4013-8. PubMed ID: 24229666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.